Medicine
Ella 30 mg tablet
Ella 30 mg tablet is a prescription medicine containing Ulipristal for oral use, marketed by PMI Branded Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20-25°C (68-77°F), excursions permitted to 15-30°C (59-86°F) Keep the…
Key facts
- Active ingredient (INN)
- Ulipristal
- Brand
- Ella
- Strength
- 30 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 1 blister pack
- Marketing authorisation holder
- PMI Branded Pharmaceuticals
- Manufacturers
- PMI Branded PharmaceuticalsA-S Medication Solutions
- Origin register
- US FDA, United States
- Storage
- Store at 20-25°C (68-77°F), excursions permitted to 15-30°C (59-86°F) Keep the blister in the outer carton in order to protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- G03AD02 Ulipristal
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 11 May 2020
- Identifiers
- RxCUI 1005924, 1005928DailyMed set ID 2bf93d23-cddd-4613-9066-5b5fa090404b, e5f09468-7ac8-40ba-a85b-758a32f586c3NDC 73302-456, 50090-5422Application NDA022474
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 blister pack in 1 carton / 1 tablet in 1 blister pack | 73302-456-01 | PMI Branded Pharmaceuticals | 11 May 2020 |
| 1 blister pack in 1 carton / 1 tablet in 1 blister pack | 50090-5422-0 | A-S Medication Solutions | 6 January 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Ulipristal is a progesterone agonist/antagonist indicated for prevention of pregnancy following unprotected intercourse or a known or suspected contraceptive failure. It is available as tablets for oral use. MedsAcross supplies Ulipristal for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about UlipristalFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Ella prescribing information (PMI Branded Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- ellaOne: European public assessment report (EPAR) · European Medicines Agency
Need Ella 30 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.